RobinRodriguezMDMBA

PubMed

• Alectinib-induced rash unresponsive to desensitization: a case report and literature review.
  Jessie Dindak, Janet Kline, Moses S Raj, Rodriguez, R.> ;BMC Pulmonary Medicine. 2023 Jul 15
• Anaplastic Lymphoma Kinase (ALK) Mutation-Targeting Treatment With Alectinib in Lung Adenocarcinoma and Primary Cutaneous Marginal Zone B-Cell Lymphoma.
  Sethi Ashish, Robin R Rodriguez, Purva Sethi, Fang Yu, Moses Raj> ;Cureus. 2022 Oct 1
• Atypical Mycobacterium Abscessus Infection in Stable Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.
  Robin R Rodriguez, Khaled Alhamad, Sohini Ghosh, Eric Bihler, Moses S Raj> ;Cureus. 2021 Dec 1
• Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review.
  Robin Raquel Rodriguez, Stephen Abel, Jyothika Mamadgi, Paul Renz, Rodney E. Wegner, Moses S. Raj> ;Journal of Gastrointestinal Cancer. 2021 Sep 6
• 5 citations
  The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report.
  Robin Raquel Rodriguez, Saleha Rizwan, Khaled Alhamad, Gene Grant Finley> ;Journal of Medical Case Reports. 2021 Mar 29
• A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
  Robin Raquel Rodriguez, Laila Babar, Herman Lo, Obaid Ashraf, Dulabh Monga, Gene Grant Finley, Lisa Doverspike, Amber Blackledge, Ashish Sethi, Moses S. Raj> ;Cureus. 2021 Jan 9
• Join now to see all

Abstracts/Posters

• Cost of care in EGFR mutant versus wild-type non-small cell lung cancer
  Vusqa U, T., Asawa P., Miller K., Sethi A., Rodriguez R, R., Friday A., & Finley G, G., ASCO, 5/26/2022
• SARS CoV-2 vaccine seroconversion and infection rates in patients on active cancer-directed therapy
  Helfand A, M., Bakalov V., Friday A., Rodriguez R, R., Walsh T., Mewawalla P., Samhouri Y., Finley G, G., ASCO, 5/26/2022
• Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A real-world perspe...
  Rizwan, S., Alhamad, K., Abel, S., Bakalov, V., Rodriguez, RR., Sethi, A., Khan, T., Attah, AA., Yasir, M., Shankar, K., Lo, H., Friday, A., Finley., GG, ASCO, 5/28/2021
• Comparison of survival outcomes with the use of combination chemoimmunotherapy versus immunotherapy alone in NSCLC with high PD-L1 expression.
  Rizwan, S., Alhamad, K., Abel, S., Rodriguez, RR., Bakalov, V., Khan, T., Sethi, A., Friday, A., Finley, GG, ASCO, 5/28/2021
• A Case for the Use of Immunotherapy Treatment in Malignant Pheochromocytomas/Paragangliomas
  Rodriguez, R.R., Rizwan, S., Alhamad, K., Finley, G.G, ACP PA Statewide Abstract, Poster and Awards Day, Virtual, 10/31/2020
• Concurrent Histoplasmosis and HSV-1 Infection after Alemtuzumab Treatment for T-cell Prolymphocytic Leukemia
  Alhamad, K., Rodriguez, R.R., Sadashiv, S, ACP PA Statewide Abstract, Poster and Awards Day, Virtual, 10/31/2020
• Join now to see all